Report From the Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration; June 15-16, 2005; Gaithersburg, Md
Circulation - United States
doi 10.1161/circulationaha.105.573105
Full Text
Open PDFAbstract
Available in full text
Date
September 27, 2005
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)